2008•Zhongguo xin yao zazhiRequires access

Advance in research of non-monoamine-targeted antidepressants

Bo‐Hua Zhong

Open publisher page 0 citations

Abstract

Most currently available antidepressants in clinic are based upon monoamine targets.The targets include 5-HT receptor,NE receptor and DA receptor.However,these antidepressants are far from fulfilling our expectations in terms of efficacy,onset of action and side effects.The increasing understanding of the molecular mechanisms of depression shows that many non-monoamine targets are also involved in depression too.The antidepressants of non-monoamine targets have become the hot research of antidepressants,and there are increasing reports of these antidepressants.The non-monoamine-targeted antidepressants exhibit high activity in receptor binding and animal models of depression;some of them are under clinical trials.The clinical trials indicate that several non-monoamine-targeted antidepressants have a faster onset of antidepressant action.In the article,we reviewed the advance in the research of non-monoamine-targeted antidepressants.

About this research paper

What this paper is about

Most currently available antidepressants in clinic are based upon monoamine targets.The targets include 5-HT receptor,NE receptor and DA receptor.However,these antidepressants are far from fulfilling our expectations in terms of efficacy,onset of action and side effects.The increasing understanding of the molecular mechanisms of depression shows that many non-monoamine targets are also involved in depression too.The antidepressants of non-monoamine targets have become the hot research of antidepressants,and there are increasing reports of these antidepressants.The non-monoamine-targeted antidepressants exhibit high activity in receptor binding and animal models of depression;some of them are under clinical trials.The clinical trials indicate that several non-monoamine-targeted antidepressants have a faster onset of antidepressant action.In the article,we reviewed the advance in the research of non-monoamine-targeted antidepressants.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Most currently available antidepressants in clinic are based upon monoamine targets.The targets include 5-HT receptor,NE receptor and DA receptor.However,these antidepressants are far from fulfilling our expectations in terms of efficacy,onset of action and side effects.The increasing understanding of the molecular mechanisms of depression shows that many non-monoamine targets are also involved in depression too.The antidepressants of non-monoamine targets have become the hot research of antidepressants,and there are increasing reports of these antidepressants.The non-monoamine-targeted antidepressants exhibit high activity in receptor binding and animal models of depression;some of them are under clinical trials.The clinical trials indicate that several non-monoamine-targeted antidepressants have a faster onset of antidepressant action.In the article,we reviewed the advance in the research of non-monoamine-targeted antidepressants.

Key concepts: Monoamine neurotransmitter, Antidepressant, Depression (economics), Animal models of depression, Pharmacology, Medicine, Psychiatry, Neuroscience

Related papers

Back to paper searchBrowse research topicsOriginal source
Advance in research of non-monoamine-targeted antidepressants — Research Paper | ScholarLens